Found: 5
Select item for more details and to access through your institution.
Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 298, p. 1, doi. 10.1126/scitranslmed.aaa7619
- By:
- Publication type:
- Article
Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1493, doi. 10.1007/s10637-011-9682-9
- By:
- Publication type:
- Article
Resveratrol in human cancer chemoprevention - Choosing the 'right' dose.
- Published in:
- Molecular Nutrition & Food Research, 2012, v. 56, n. 1, p. 7, doi. 10.1002/mnfr.201100400
- By:
- Publication type:
- Article
Clinical trials of resveratrol.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1215, n. 1, p. 161, doi. 10.1111/j.1749-6632.2010.05853.x
- By:
- Publication type:
- Article
A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI<sup>™</sup>), in patients with advanced solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 425, doi. 10.1007/s00280-009-0968-y
- By:
- Publication type:
- Article